These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 28542263)

  • 1. Inflammatory biomarkers as predictors of heart failure in women without obstructive coronary artery disease: A report from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE).
    AlBadri A; Lai K; Wei J; Landes S; Mehta PK; Li Q; Johnson D; Reis SE; Kelsey SF; Bittner V; Sopko G; Shaw LJ; Pepine CJ; Bairey Merz CN
    PLoS One; 2017; 12(5):e0177684. PubMed ID: 28542263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heart failure hospitalization in women with signs and symptoms of ischemia: A report from the women's ischemia syndrome evaluation study.
    Bakir M; Nelson MD; Jones E; Li Q; Wei J; Sharif B; Minissian M; Shufelt C; Sopko G; Pepine CJ; Merz CNB
    Int J Cardiol; 2016 Nov; 223():936-939. PubMed ID: 27589041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multimarker approach predicts adverse cardiovascular events in women evaluated for suspected ischemia: results from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation.
    Arant CB; Wessel TR; Ridker PM; Olson MB; Reis SE; Delia Johnson B; Sharaf BL; Pauly DF; Handberg E; Zineh I; Sopko G; Kelsey SF; Noel Bairey Merz C; Pepine CJ
    Clin Cardiol; 2009 May; 32(5):244-50. PubMed ID: 19452486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse outcomes among women presenting with signs and symptoms of ischemia and no obstructive coronary artery disease: findings from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE) angiographic core laboratory.
    Sharaf B; Wood T; Shaw L; Johnson BD; Kelsey S; Anderson RD; Pepine CJ; Bairey Merz CN
    Am Heart J; 2013 Jul; 166(1):134-41. PubMed ID: 23816032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).
    Johnson BD; Kip KE; Marroquin OC; Ridker PM; Kelsey SF; Shaw LJ; Pepine CJ; Sharaf B; Bairey Merz CN; Sopko G; Olson MB; Reis SE;
    Circulation; 2004 Feb; 109(6):726-32. PubMed ID: 14970107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of coronary reactivity testing in women with no obstructive coronary artery disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) study.
    Wei J; Mehta PK; Johnson BD; Samuels B; Kar S; Anderson RD; Azarbal B; Petersen J; Sharaf B; Handberg E; Shufelt C; Kothawade K; Sopko G; Lerman A; Shaw L; Kelsey SF; Pepine CJ; Merz CN
    JACC Cardiovasc Interv; 2012 Jun; 5(6):646-53. PubMed ID: 22721660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brachial artery constriction during brachial artery reactivity testing predicts major adverse clinical outcomes in women with suspected myocardial ischemia: results from the NHLBI-sponsored women's ischemia Syndrome Evaluation (WISE) Study.
    Sedlak TL; Johnson BD; Pepine CJ; Reis SE; Bairey Merz CN
    PLoS One; 2013; 8(9):e74585. PubMed ID: 24058592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TIMI frame count and adverse events in women with no obstructive coronary disease: a pilot study from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE).
    Petersen JW; Johnson BD; Kip KE; Anderson RD; Handberg EM; Sharaf B; Mehta PK; Kelsey SF; Merz CN; Pepine CJ
    PLoS One; 2014; 9(5):e96630. PubMed ID: 24800739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angina Hospitalization Rates in Women With Signs and Symptoms of Ischemia But no Obstructive Coronary Artery Disease: A Report from the WISE (Women's Ischemia Syndrome Evaluation) Study.
    Aldiwani H; Zaya M; Suppogu N; Quesada O; Johnson BD; Mehta PK; Shufelt C; Petersen J; Azarbal B; Samuels B; Anderson RD; Shaw LJ; Kar S; Handberg E; Kelsey SF; Pepine CJ; Bairey Merz CN
    J Am Heart Assoc; 2020 Feb; 9(4):e013168. PubMed ID: 32063125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognosis in women with myocardial ischemia in the absence of obstructive coronary disease: results from the National Institutes of Health-National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).
    Johnson BD; Shaw LJ; Buchthal SD; Bairey Merz CN; Kim HW; Scott KN; Doyle M; Olson MB; Pepine CJ; den Hollander J; Sharaf B; Rogers WJ; Mankad S; Forder JR; Kelsey SF; Pohost GM;
    Circulation; 2004 Jun; 109(24):2993-9. PubMed ID: 15197152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Even "WISE-R?"-an Update on the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation.
    Barsky L; Merz CNB; Wei J; Shufelt C; Handberg E; Pepine C; Rutledge T; Reis S; Doyle M; Rogers W; Shaw L; Sopko G
    Curr Atheroscler Rep; 2020 Jun; 22(8):35. PubMed ID: 32556630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of Coronary Endothelial and Microvascular Dysfunction in Women with Symptoms of Ischemia and No Obstructive Coronary Artery Disease Is Confirmed by a New Cohort: The NHLBI-Sponsored Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD).
    Anderson RD; Petersen JW; Mehta PK; Wei J; Johnson BD; Handberg EM; Kar S; Samuels B; Azarbal B; Kothawade K; Kelsey SF; Sharaf B; Shaw LJ; Sopko G; Bairey Merz CN; Pepine CJ
    J Interv Cardiol; 2019; 2019():7169275. PubMed ID: 31772544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Echocardiographic Features of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.
    Shah AM; Cikes M; Prasad N; Li G; Getchevski S; Claggett B; Rizkala A; Lukashevich I; O'Meara E; Ryan JJ; Shah SJ; Mullens W; Zile MR; Lam CSP; McMurray JJV; Solomon SD;
    J Am Coll Cardiol; 2019 Dec; 74(23):2858-2873. PubMed ID: 31806129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular and mortality risk of apparent resistant hypertension in women with suspected myocardial ischemia: a report from the NHLBI-sponsored WISE Study.
    Smith SM; Huo T; Delia Johnson B; Bittner V; Kelsey SF; Vido Thompson D; Noel Bairey Merz C; Pepine CJ; Cooper-Dehoff RM
    J Am Heart Assoc; 2014 Feb; 3(1):e000660. PubMed ID: 24584740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depression symptom severity and reported treatment history in the prediction of cardiac risk in women with suspected myocardial ischemia: The NHLBI-sponsored WISE study.
    Rutledge T; Reis SE; Olson MB; Owens J; Kelsey SF; Pepine CJ; Mankad S; Rogers WJ; Merz CN; Sopko G; Cornell CE; Sharaf B; Matthews KA; Vaccarino V
    Arch Gen Psychiatry; 2006 Aug; 63(8):874-80. PubMed ID: 16894063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Weight cycling and cardiovascular outcome in women with suspected ischemia: A report from the NHLBI-sponsored WISE Study.
    Bairey Merz CN; Olson MB; Kelsey SF; Bittner V; Reis SE; Reichek N; Handberg E
    PLoS One; 2018; 13(12):e0207223. PubMed ID: 30507935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anginal symptoms, coronary artery disease, and adverse outcomes in Black and White women: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) study.
    Eastwood JA; Johnson BD; Rutledge T; Bittner V; Whittaker KS; Krantz DS; Cornell CE; Eteiba W; Handberg E; Vido D; Bairey Merz CN
    J Womens Health (Larchmt); 2013 Sep; 22(9):724-32. PubMed ID: 23992103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depressive symptom dimensions and cardiovascular prognosis among women with suspected myocardial ischemia: A report from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation.
    Linke SE; Rutledge T; Johnson BD; Vaccarino V; Bittner V; Cornell CE; Eteiba W; Sheps DS; Krantz DS; Parashar S; Bairey Merz CN
    Arch Gen Psychiatry; 2009 May; 66(5):499-507. PubMed ID: 19414709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ischemic Heart Disease Modifies the Association of Atrial Fibrillation With Mortality in Heart Failure With Reduced Ejection Fraction.
    Mercer BN; Koshy A; Drozd M; Walker AMN; Patel PA; Kearney L; Gierula J; Paton MF; Lowry JE; Kearney MT; Cubbon RM; Witte KK
    J Am Heart Assoc; 2018 Oct; 7(20):e009770. PubMed ID: 30371286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-Sensitivity Troponin I in Hospitalized and Ambulatory Patients With Heart Failure With Preserved Ejection Fraction: Insights From the Heart Failure Clinical Research Network.
    Fudim M; Ambrosy AP; Sun JL; Anstrom KJ; Bart BA; Butler J; AbouEzzeddine O; Greene SJ; Mentz RJ; Redfield MM; Reddy YNV; Vaduganathan M; Braunwald E; Hernandez AF; Borlaug BA; Felker GM
    J Am Heart Assoc; 2018 Dec; 7(24):e010364. PubMed ID: 30561266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.